You do realize the market exists to help companies raise capital for things like new locations and script robots right? Not so traders can flip ownership back and forth.
Ever heard of companies going public? To raise money from public to expand or start new business. Now 2 locations debt free and online presence growing and getting closer to acquire 3rd one. SEC filing expected to start in 2019 and most probably uplisting to Nasdaq. Show me the similar company in the OTC. It's my 3 years holding RXMD and no one so far provided the answer. Still waiting.
$RXMD = GREAT INVESTMENT, 20 MILLION REVS RXMD IS ON A COURSE FOR SUCCESS, ON OTCQB and NASDAQ
OUTLOOK FOR 2018: Completion of TWO REVENUE PRODUCING ACQUISTIONS (TouchPointRX Complete) OUTLOOK FOR 2019: SEC Reporting Compliance, NASDAQ Uplist, and more ACQUISITIONS ALL POINTS TO CONTINUED DEVELOPMENT AND GROWTH THROUGH EXPANSION ****INVEST WISELY****
WITH EXTREMELY LOW SHARE STRUCTURE UPDATED RXMD Security Details Share Structure Authorized Shares 500,000,000 07/31/2018 Outstanding Shares 428,997,097 07/31/2018 will likely raise to 430,901,000 for completion of the latest clearing of debt conversion with CV for acquisition. This balance also includes 5,590,432 common shares that were beneficially owned by Progressive Care through PharmCo, LLC and Progressive Training, Inc. So actual amount is roughly 425 million Outstanding on F/S. Restricted 83,599,982 07/17/2018 Unrestricted 345,397,115 07/17/2018 Float 334,506,590 03/31/2018
***THE REAL DEAL*** TWO REAL BRICK AND MORTAR LOCATIONS SERVICING: MIAMI DADE COUNTY, FLORIDA MARTIN COUNTY, FLORIDA PALM BEACH COUNTY, FLORIDA BROWARD COUNTY, FLORIDA 63 Employees 2 YEARS AUDITED FINANCIAL STATEMENTS OTCQB with INDEPENDENT BOARD and AUDIT COMMITTEE MEMBERS
HERES SOME JUICY 2018 NUMBERS - W/O NEW LOCATION ACQUIRED 3/30/18, these revenues will start to be recognized June 30, 2018 Scripts: 132,100 a 22% increase compared to June 30, 2017 Net Revenue: $10.2 million, a $160,000+ increase compared to June 30, 2017 340B Sales: $2.8 million, a $1.73 million+ increase compared to June 30, 2017 Annualized, 2018 340B Sales are estimated at $6.1 Million, that's a 120% increase of 2017's $2.75 Million. PharmCoRX is obviously increasing the number of customers.
Then let’s observe increase in revenue last year. JUST KEEPS INCREASING YOY Then check out increase in revenue from the last 2 years. Overall G - FY 2013 = $9.3 million R - FY 2014 = $11.3 million O - FY 2015 = $13.7 million W - FY 2016 = $18.3 million (AUDITED) T - FY 2017 = $20.1 million (AUDITED) does not include 340B revenues of $2.75 million H - FY 2018 = $10.2 million (6 months) does not include 340B revenues of $2.8 million
[color=blue]EVERYTHING IS MOVING FORWARDS AND LOOKING GREAT !!! Another Acquisition Scheduled for 2018 Another Acquisition, SEC Reporting Compliance, and NASDAQ Uplifting for early 2019